FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003318708> ?p ?o ?g. }

• W3003318708 abstract "Background Several trials have demonstrated protective effects from inhibition of sodium‐glucose cotransporter 2 among patients with type 2 diabetes mellitus. There is uncertainty about the consistency of the cardiovascular benefits achieved across patient subsets. Methods and Results We included 4 large‐scale trials of sodium‐glucose cotransporter 2 inhibition compared with placebo in patients with diabetes mellitus that reported effects on cardiovascular outcomes overall and for participant subgroups defined at baseline by cardiovascular disease, reduced kidney function, and heart failure. Fixed effects models with inverse variance weighting were used to estimate summary hazard ratios and 95% CIs . There were 38 723 patients from 4 trials, with a mean 2.9 years of follow‐up. Of the patients, 22 870 (59%) had cardiovascular disease, 7754 (20%) had reduced kidney function, and 4543 (12%) had heart failure. There were 3828 major adverse cardiac events. There was overall benefit for major adverse cardiac events (0.88; 95% CI , 0.82–0.94; P <0.001) and no evidence that the effects of sodium‐glucose cotransporter 2 inhibition varied across patient subgroups, defined by the presence of cardiovascular disease or heart failure at baseline (all P interaction >0.252; I 2 <25%). All patient subgroups benefited with respect to hospitalization for heart failure (all P interaction>0.302; I 2 <10%), cardiovascular death (all P interaction>0.167; I 2 <50%), and death from any cause (all P interaction>0.354; I 2 =0%). The only difference in effects across subgroups was for stroke, with protection observed among those with reduced kidney function but not those with preserved kidney function ( P interaction=0.020; I 2 =81%). Conclusions Sodium‐glucose cotransporter 2 inhibitors protect against cardiovascular disease and death in diverse subsets of patients with type 2 diabetes mellitus regardless of cardiovascular disease history." @default.
• W3003318708 created "2020-02-07" @default.
• W3003318708 creator A5015488634 @default.
• W3003318708 creator A5015704931 @default.
• W3003318708 creator A5026602252 @default.
• W3003318708 creator A5027520502 @default.
• W3003318708 creator A5038059770 @default.
• W3003318708 creator A5039432822 @default.
• W3003318708 creator A5040550338 @default.
• W3003318708 creator A5056130529 @default.
• W3003318708 creator A5067422552 @default.
• W3003318708 creator A5069771802 @default.
• W3003318708 creator A5075162144 @default.
• W3003318708 creator A5087474773 @default.
• W3003318708 date "2020-02-04" @default.
• W3003318708 modified "2023-10-11" @default.
• W3003318708 title "Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis" @default.
• W3003318708 cites W1617328014 @default.
• W3003318708 cites W1809230663 @default.
• W3003318708 cites W2072040765 @default.
• W3003318708 cites W2098923148 @default.
• W3003318708 cites W2146264128 @default.
• W3003318708 cites W2150959326 @default.
• W3003318708 cites W2273304042 @default.
• W3003318708 cites W2341643234 @default.
• W3003318708 cites W2407717047 @default.
• W3003318708 cites W2424539745 @default.
• W3003318708 cites W2565236356 @default.
• W3003318708 cites W2604277961 @default.
• W3003318708 cites W2626446274 @default.
• W3003318708 cites W2756191633 @default.
• W3003318708 cites W2768576350 @default.
• W3003318708 cites W2774743973 @default.
• W3003318708 cites W2808725516 @default.
• W3003318708 cites W2833091206 @default.
• W3003318708 cites W2894993577 @default.
• W3003318708 cites W2899764361 @default.
• W3003318708 cites W2900413769 @default.
• W3003318708 cites W2902527999 @default.
• W3003318708 cites W2903431537 @default.
• W3003318708 cites W2908457468 @default.
• W3003318708 cites W2916296804 @default.
• W3003318708 cites W2919368874 @default.
• W3003318708 cites W2921866736 @default.
• W3003318708 cites W2939222610 @default.
• W3003318708 cites W2943200535 @default.
• W3003318708 cites W2947319348 @default.
• W3003318708 cites W2965056983 @default.
• W3003318708 cites W2974260792 @default.
• W3003318708 cites W2989060738 @default.
• W3003318708 doi "https://doi.org/10.1161/jaha.119.014908" @default.
• W3003318708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7033896" @default.
• W3003318708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31992158" @default.
• W3003318708 hasPublicationYear "2020" @default.
• W3003318708 type Work @default.
• W3003318708 sameAs 3003318708 @default.
• W3003318708 citedByCount "147" @default.
• W3003318708 countsByYear W30033187082020 @default.
• W3003318708 countsByYear W30033187082021 @default.
• W3003318708 countsByYear W30033187082022 @default.
• W3003318708 countsByYear W30033187082023 @default.
• W3003318708 crossrefType "journal-article" @default.
• W3003318708 hasAuthorship W3003318708A5015488634 @default.
• W3003318708 hasAuthorship W3003318708A5015704931 @default.
• W3003318708 hasAuthorship W3003318708A5026602252 @default.
• W3003318708 hasAuthorship W3003318708A5027520502 @default.
• W3003318708 hasAuthorship W3003318708A5038059770 @default.
• W3003318708 hasAuthorship W3003318708A5039432822 @default.
• W3003318708 hasAuthorship W3003318708A5040550338 @default.
• W3003318708 hasAuthorship W3003318708A5056130529 @default.
• W3003318708 hasAuthorship W3003318708A5067422552 @default.
• W3003318708 hasAuthorship W3003318708A5069771802 @default.
• W3003318708 hasAuthorship W3003318708A5075162144 @default.
• W3003318708 hasAuthorship W3003318708A5087474773 @default.
• W3003318708 hasBestOaLocation W30033187081 @default.
• W3003318708 hasConcept C111566952 @default.
• W3003318708 hasConcept C126322002 @default.
• W3003318708 hasConcept C134018914 @default.
• W3003318708 hasConcept C142724271 @default.
• W3003318708 hasConcept C159641895 @default.
• W3003318708 hasConcept C164705383 @default.
• W3003318708 hasConcept C178790620 @default.
• W3003318708 hasConcept C185592680 @default.
• W3003318708 hasConcept C188053792 @default.
• W3003318708 hasConcept C197934379 @default.
• W3003318708 hasConcept C204787440 @default.
• W3003318708 hasConcept C207103383 @default.
• W3003318708 hasConcept C27081682 @default.
• W3003318708 hasConcept C2777180221 @default.
• W3003318708 hasConcept C2778198053 @default.
• W3003318708 hasConcept C2910068830 @default.
• W3003318708 hasConcept C44249647 @default.
• W3003318708 hasConcept C537181965 @default.
• W3003318708 hasConcept C555293320 @default.
• W3003318708 hasConcept C71924100 @default.
• W3003318708 hasConceptScore W3003318708C111566952 @default.
• W3003318708 hasConceptScore W3003318708C126322002 @default.
• W3003318708 hasConceptScore W3003318708C134018914 @default.
• W3003318708 hasConceptScore W3003318708C142724271 @default.
• W3003318708 hasConceptScore W3003318708C159641895 @default.

• next